Data as of Dec 10
| +0.30 / +0.51%|
The 17 analysts offering 12-month price forecasts for St. Jude Medical Inc have a median target of 60.00, with a high estimate of 66.00 and a low estimate of 41.00. The median estimate represents a +0.99% increase from the last price of 59.41.
The current consensus among 24 polled investment analysts is to Hold stock in St. Jude Medical Inc. This rating has held steady since November, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.